LFVN | LifeVantage Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	12.94 - 12.94
52 Week Range	5.22 - 15.15
Beta	0.83
Implied Volatility	118.35%
IV Rank	35.49%
Day's Volume	1,526
Average Volume	102,478
Shares Outstanding	12,525,200
Market Cap	162,076,088
Sector	Consumer Defensive
Industry	Packaged Foods
IPO Date	1994-04-07

Valuation
Profitability
Growth
Health
P/E Ratio	40.44
Forward P/E Ratio	12.12
EPS	0.32
1YR Price Target	N/A
Dividend Yield	1.18%
Dividend Per Share	0.15
Dividend ExDate	2022-11-30
Dividend PayDate	2022-12-15
Employees	222
Country	USA
Website	LFVN

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

LFVN's peers: CENT, CENTA, SENEB, LWAY, SENEA, JJSF, ARZTY, JVA, NATR, BRID, MMMB, MKC-V, NAII, PETZ, RGF, NCRA

*Chart delayed

Analyzing fundamentals for LFVN we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is desperately bad and Health is very strong. For more detailed analysis please see LFVN Fundamentals page.

Watching at LFVN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LFVN Technicals page.